Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of healthcare supplies, announced today that it was awarded a contracting agreement for monitoring electrodes from MedAssets, a leading financial improvement partner to more than 4,000 acute-care hospitals and 90,000 non-acute healthcare providers.
 
This agreement demonstrates MedAssets' continued commitment to the pre-commitment model, which aggregates customers' committed purchasing volume and increases their percentage of savings for non-labor supplies and services. The three-year agreement runs through February 2014.  The agreement is estimated to be worth up to $22 million, based on expected annual purchase volume.
 
The contracting agreement includes Medline's complete line of monitoring electrodes designed for use hospital-wide, including specialized electrodes for ICU/CCU, surgery, emergency services, stress testing, holter monitoring and the NICU.
 
"Our electrodes were evaluated by 34 hospitals before being selected for the MedAssets' contract," said Kurt Krieghbaum, Medline's Senior Vice President, National Accounts.  "We're proud that we can provide quality products at a great value to MedAssets customers and are expected to save MedAssets' GPO customers more than 18 percent from their current pricing."  

About MedAssets
MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve financial strength by implementing spend management and revenue cycle management solutions that help control cost, improve margins and cash flow, increase regulatory compliance and optimize operational efficiency. MedAssets serves more than 180 health systems, 4,000 hospitals and 90,000 non-acute healthcare providers. For more information, go to www.medassets.com.